The results of a recent study presented at the 2023 Hematology/Oncology Pharmacy Association annual conference suggest health care providers should be vigilant about the overutilization of potentially...
In a recent study presented at the Hematology/Oncology Pharmacy Association annual conference, researchers examined the use of opioids in patients with head and neck squamous cell carcinoma while undergoing...
The FDA approves the first-of-its-kind treatment for anemia caused by CKD for adults who receive dialysis following the results of a randomized clinical trial.
Several major professional organizations have released a joint statement on the prevention of central line-associated bloodstream infections in acute-care hospitals.
The FDA has approved the first therapy specifically indicated (in combination with plasma exchange and immunosuppressive therapy) for the treatment of adults with acquired thrombotic thrombocytopenic...
The authors of a new study investigated the impact of various complications—such as gastrointestinal bleeding, intracranial hemorrhage, and septicemia—on hospital length-of-stay and mortality risk among...
The authors of a new study investigated the impact of various complications—such as gastrointestinal bleeding, intracranial hemorrhage, and septicemia—on hospital length-of-stay and mortality risk among...
